Sponsor Pipeline

Shenzhen Celconta Life Science Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07043907 PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in… Stage IIIA Non-small Cell Lung Cancer Not Yet Recruiting
Phase 1
NCT06782425 Treating Claudin18.2-positive Advanced Solid Tumors with XKDCT225(Targeting… Claudin18.2 Positive Advanced Solid Tumors Recruiting
NCT06897228 PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in… Solid Tumors, Adult Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Shenzhen Celconta Life Science Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free